October 5-7 | Arizona Biltmore

18 Jul CPTx

Posted at 18:19h in by Brittany Miller

Hendrik Dietz, Ph.D., CEO

Oct. 8 | 10:30am | FLW Ballroom F

Munich, Germany

(Private)

CPTx is redefining the future of genetic medicine through a single-stranded DNA (ssDNA) platform that enables safer, redosable, and scalable gene therapies. The lead proprietary development program is a new kind of in vivo CAR T-cell therapy using immune-silent single-stranded DNA (ssDNA) delivered with LNPs, enabling repeat dosing, and controllable, long-lasting effects, something not possible with viral vectors or mRNA.

www.cptx.bio

About the Event

The Cell & Gene Meeting on the Mesa is the sector’s foremost annual conference bringing together senior executives and top decision-makers in the industry to advance cutting-edge research into cures. Tackling the commercialization hurdles facing the cell and gene therapy sector today, this meeting covers a wide range of topics from clinical trial design to alternative payment models to scale-up and supply chain platforms for advanced therapies. The program features expert-led panels, extensive partnering capabilities, exclusive networking opportunities, and 110+ dedicated presentations by the leading publicly traded and privately held companies in the space. Attracting over 1,500 attendees – over 30% of which are C-level executives – this conference enables key partnerships through more than 5,000 one-on-one meetings while highlighting the significant clinical and commercial progress in the field.

Dates & Location

October 5-7, 2026
Arizona Biltmore
Phoenix, AZ

Program Organizer

By using this website you agree to accept our Privacy Policy and Terms & Conditions